H.C. Wainwright more than doubles its price target to $7.00, citing growing cost-competitiveness for the green hydrogen industry.
Agreement with White Lion Capital gives the network solutions provider the right to sell shares, securing access to growth capital.
Regulators expedite review for ALTO-101, a novel treatment for cognitive impairment in schizophrenia, a condition with no currently approved therapies.
A significant analyst price target hike for Quantum Computing Inc. (QUBT) fuels a massive rally in the leveraged ETF.
Shares surge over 76% as the company secures Nevada Tech Hub funding and a key U.S. patent for its charging technology.
Health insurer's stock rallies as it maintains financial targets despite recent Medicare Star Ratings challenges.
Singapore-based security firm Concorde International Group sees massive trading volume without any apparent news catalyst, prompting investor caution.
Government award will advance the company's non-vaccine influenza therapeutic, CD388, and onshore its manufacturing ahead of a potential pandemic.